Apollon Wealth Management’s Bio-Techne TECH Stock Holding History

Apollon Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,522	Closed	-$207K	–	1462
2025 Q4	$207K	Buy	+3,522	New	+$214K	﹤0.01%	1216

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Apollon Wealth Management's TECH Position: Q1 2026 in Review

Apollon Wealth Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 3,522 shares — an estimated $207K sold.

Apollon Wealth Management first reported a position in TECH in Q4 2025 and held it in 1 quarter. The position peaked at $207K in Q4 2025. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Apollon Wealth Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
Apollon Wealth Management sold 3,522 Bio-Techne shares in Q1 2026, an estimated $207K.
Apollon Wealth Management first reported a position in Bio-Techne in Q4 2025 and held it in 1 quarter.
Apollon Wealth Management's Bio-Techne position peaked at $207K in Q4 2025.
584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.